Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05388032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sodium Lowering Vascular Effects Trial

Study acronym: SOLVE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 11 words
    • Study description revised
    • Site details revised
  2. Primary and study completion dates: Jun 30, 2026 to Dec 31, 2026v7
  3. Start date: Jan 2, 2023 to Jan 25, 2023v6
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v5
  5. Start date: Dec 1, 2022 to Jan 2, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Oct 15, 2022 to Dec 1, 2022
    • Study description shortened, about 59 words
    • Eligibility criteria shortened, about 2 words
    v3
  2. Start date: Jul 1, 2022 to Oct 15, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiovascular disease risk in addition to blood pressure and could provide further evidence on sodium reduction for the prevention of cardiovascular disease.
Trial Details
NCT Number NCT05388032
Lead Sponsor Tulane University
Collaborators: Johns Hopkins University
Conditions
(from sponsor)		 Endothelial Dysfunction, Vascular Stiffness, Left Ventricular Hypertrophy, Left Ventricular Dysfunction
Related terms Hypertrophy, Left Ventricular, Ventricular Dysfunction, Left
Enrollment 256 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov